Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization

Journal of the American College of Cardiology

Volumn 31, Issue 5, 1998, Pages 1040-1048

  Baer, Frank M ^a   Theissen, Peter ^a   Schneider, Christian A ^a   Voth, Eberhard ^a   Sechtem, Udo ^b   Schicha, Harald ^a   Erdmann, Erland ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE;

ADULT; AGED; ARTICLE; CORONARY ARTERY BYPASS GRAFT; DIAGNOSTIC ACCURACY; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; AGED; CARDIOTONIC AGENTS; CHRONIC DISEASE; CORONARY ANGIOGRAPHY; DOBUTAMINE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0032054751     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00032-1     Document Type: Article

References (33)

1. Detre K, Peduzzi P, Murphy M, et al. Effect of bypass surgery on survival in patients in low and high risk subgroups delineated by the use of simple clinical variables. Circulation 1981;63:1329-38.
2. Kent KM, Bonow RO, Rosing DR, et al. Improved myocardial function during exercise after successful percutaneous transluminal coronary angioplasty. N Engl J Med 1982;306:441-6.
3. Gould KL. Myocardial viability: what does it mean and how to measure it? Circulation 1991;83:333-5.
4. Bonow OR, Dilsizian V, Cuocolo A, Bacharach SL. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Circulation 1991;83:26-37.
5. Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall motion abnormalities predicted by positron tomography. N Engl J Med 1986;314: 884-8.
6. Tamaki N, Yonekura Y, Yamashita K, et al. Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol 1989;64:860-5.
7. Pierard LA, DeLandsheere CM, Berthe C, Rigo P, Kulbertus HE. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardiol 1990;15: 1021-31.
8. Afridi I, Kleiman NS, Raizner AE, Zoghbi WA. Dobutamine echocardiography in myocardial hibernation. Circulation 1995;91:663-70.
9. 18F-fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 1994;24:343-53.
10. Higgins CB, Lanzer P, Stark D, et al. Imaging by nuclear magnetic resonance in patients with chronic ischemic heart disease. Circulation 1984;69:523-31.
11. Akins WE, Hill JA, Sievers KW, Conti CR. Assessment of left ventricular wall thickness in healed myocardial infarction by magnetic resonance imaging. Am J Cardiol 1987;59:24-8.
12. Sechtem U, Voth E, Baer FM, Schneider C, Theissen P, Schicha H. Assessment of residual viability in patients with myocardial infarction using magnetic resonance techniques. Int J Card Imaging 1993;9:31-40.
13. 99mTc-methoxyisobutyl-isonitrile uptake at rest in patients with myocardial infarcts: comparison with morphological and functional parameters obtained from gradient-echo magnetic resonance imaging. Eur Heart J 1994;15:97-107.
14. van Rugge FP, van der Wall EE, Spanderberg SJ, et al. Magnetic resonance imaging during dobutamine stress for detection and localization of coronary artery disease. Circulation 1994;90:127-38.
15. Baer FM, Voth E, LaRosee K, et al. Comparison of dobutamine-transesophageal echocardiography and dobutamine-magnetic resonance imaging for the detection of residual myocardial viability. Am J Cardiol 1996;78:415-9.
16. Baer FM, Voth E, Schneider CA, et al. Dobutamine-gradient echo MRI: a functional and morphologic approach to the detection of residual myocardial viability. Circulation 1995;91:1006-15.
17. Perrone-Filardi P, Bacharach SL, Dilsizian V, Maurea S, Frank JA, Bonow RO. Regional left ventricular wall thickening: relation to regional uptake of FDG and thallium-201 in patients with chronic coronary artery disease and left ventricular dysfunction. Circulation 1992;86:1125-37.
18. Atkinson DJ, Edelmann RR. Cineangiography of the heart in a single breath hold with a segmented turbo FLASH sequence. Radiology 1991;178:357-60.
19. 99mTc-methoxyisobutyl-isonitrile-SPECT. Am Heart J 1992;123:636-45.
20. Popio KA, Gorlin R, Bechtel D, Levine JA. Postextrasystolic potentiation as a predictor of potential myocardial viability: preoperative analyses compared with studies after coronary bypass surgery. Am J Cardiol 1977;39:944-51.
21. Rahimtoola SH. A perspective on the three larger multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation 1985;72 Suppl V:V-123-35.
22. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989;17:211-21.
23. Braunwald E, Rutherford J. Reversible ischemic left ventricular dysfunction: evidence of the "hibernating myocardium." J Am Coll Cardiol 1986;8:1467-70.
24. Dubnow MH, Burchell HB, Titus JL. Postinfarction ventricular aneurysm: a clinicomorphologic and electrocardiographic study of 80 cases. Am Heart J 1965;70:753-60.
25. Bodenheimer MM, Banka VS, Hermann GA, Trout RG, Pasdar H, Helfant R. Reversible asynergy: histopathologic and electrocardiographic correlations in patients with coronary artery disease. Circulation 1979;53:792-6.
26. Nesto RW, Cohn LH, Collins JJ, Wynne J, Holman L, Cohn PF. Inotropic contractile reserve: a useful predictor of increased 5-year survival and improved postoperative left ventricular function in patients with coronary artery disease and reduced ejection fraction. Am J Cardiol 1982;50:39-44.
27. Popio KA, Gorlin R, Bechtel D, Levine JA. Postextrasystolic potentiation as a predictor of potential myocardial viability: preoperative analyses compared with studies after coronary bypass surgery. Am J Cardiol 1977;39:944-51.
28. Horn HR, Teichholz LE, Cohn PF, Herman MV, Gorlin R. Augmentation of left ventricular contraction pattern in coronary artery disease by an inotropic catecholamine: the epinephrine ventriculogram. Circulation 1974; 49:1063-71.
29. Panza JA, Dilsizian V, Laurienzo JM, Curiel RV, Katsiyiannis PT. Relation between thallium uptake and contractile response to dobutamine. Circulation 1995;91:990-8.
30. LaCanna G, Alfieri O, Giubbini R, Gargano M, Ferrari R, Visioli O. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol 1994;23:617-27.
31. Cigarroa CG, deFilippi CR, Brickner ME, Alvarez LG, Wait MA, Grayburn PA. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation 1993;88:430-6.
32. Perrone-Filardi P, Pace L, Prastaro M, et al. Dobutamine-echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease. Circulation 1995; 91:2556-65.
33. Bax JJ, Cornel JH, Visser VC, et al. Prediction of improvement of contractile function in patients with ischemic ventricular dysfunction after revascularization by fluorine-18 fluorodeoxyglucose single-photon emission computed tomography. J Am Coll Cardiol 1997;30:377-83.